SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (NASDAQ: PURE), the creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced it has initiated testing of SDC-based formulas in direct food applications to determine efficacy in reducing food borne pathogens such as Listeria, E. coli and Salmonella. The new testing program builds on the earlier GRAS designation for SDC on food contact surfaces.
